A

Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study

The Lancet Oncology

Authors 0

  1. Author list not loaded yet.

Cited by 13 stored of 581

13 results

References 0